The causal linkage between retinal ischaemia and ocular neovascularisation has been recog nised and widely accepted by the ophthalmic community since the early pioneering work of Michaelson/ Ashton, 2 Patz,3 Wise,4 and many others. In the initial stages of this research, the presence of retinal vascular occlusion in eyes with neovascular retinopath ies was surmised primarily on the basis of his tological specimens of the retinal vessels obtained from autopsy eyes of patients with diabetic retinopathy. Trypsin digestion prep aration of the retinal vasculature showed focal areas of capillary acellularity, which were interpreted as being nonperfused capillaries in life. 5.6 Subsequently, the development of fluorescein angiography of the retinal vessels allowed assessment of their perfusion status in the living eye. In the case of diabetic ret inopathy, focal nonperfusion of the retinal capillary bed, as well as of arterioles in the more advanced stages of the disease, was demonstrated angiographically. In a few cases in which both in vivo fluorescein angiography and post mortem trypsin digestion prep arations were available, clinicopathological correlation studies showed a topographical correlation between capillary acellularity and angiographic nonperfusion. 7 , 8,9 Numerous clinical studies over the years support the notion that retinal ischaemia pro vokes ocular neovascularisation. Both cross sectional and longitudinal studies have demonstrated the following: (1) retinal vascular growth in diabetic retino pathy and in sickle cell retinopathy pref erentially occur at the border between perfused and nonperfused retinal zones, lO,11 (2) disc neovascularisation in diabetic retino pathy occurs mainly in eyes with exten sive mid-peripheral or generalised capillary nonperfusion,1 2 (3) iris neovascularisation in central retinal vein occlusion (CRVO) is found primarily in eyes with widespread retinal vascular nonperfusion. 13 , 14 , 15 , 16 In a recent large-scale longitudinal study of eyes with non proliferative diabetic retino pathy (NPDR), the extent of capillary non perfusion, arteriolar abnormalities, and fluorescein leakage present at the baseline visit, (as measured by a standardised angio. graphic grading system) were significant risk factors for the subsequent development of proliferative retinopathy (PDR). 17 The differ ence in rates of developing new vessels within one year between eyes with and without these abnormalities ranged from two to threefold, depending upon the subgroup of NPDR sev erity considered. On the basis of this study, it is clear that fluorescein angiography is a useful tool in assessing the risk for neovascularisa tion in eyes with NPDR.
Besides determining the anatomic exten� of nonperfusion in eyes with vascular retina· pathy, evaluating the effects of ischaemia on various functions of the eye can also be useful. The major test, in this respect, has been elec troretinography, although other measures such as perimetrl8 and pupillary lighf response18 have been used. Conventional electroretinography (ERG) is a non-invasive test that reflects the light-induced electrical activity of the outer and middle layers of the, retina throughout its entire extent; therefore, it can relatively easily detect extensive 01 generalised ischaemia. As example, ampli. tude reductions in the oscillatory potentials of the ERG have been shown to have prognostic value in predicting the onset and severity of PDR development, especially new vessels on the disc. 19 ,2 0, 21 ,22 On the other hand, the conventional ERG is relatively insensitive to focal abnormalities in the retinal vascular bed. The same can be said for the relative afferent pupillary defect (RAPD), which has been claimed to be a good predictor of the development of neovas cularisation of the iris (NVI) in eyes with widespread retinal vascular non perfusion due to CRVO. 18 Perimetry has the theoretical advantage of being able to identify localised zones of decreased retinal sensitivity due to focal ischaemia 2 3 ,2 4, as well as a more general ised decrease in sensitivity from widespread ischaemia and perhaps also metabolic abnormalities. While perimetry has not yet been shown to be a useful clinical tool to pre dict focal neovascularisation in conditions such as diabetic or sickle retinopathies, it does have predictive value for NVI in eyes with CRVO. 18 The typical findings on fluorescein angiog raphy and ERG testing, the interpretation of the results of these tests, and the usefulness of the tests in identifying eyes at risk for neovas cularisation, vary with different disease enti ties. Three disorders that are representative of the spectrum of findings in retinal vascular disease are:
(1) diabetic retinopathy, which exhibits focal retinal ischaemia but can show as well . more widespread retinal abnormality due to retinal vascular leakage and metabolic derangement;
(2) central retinal vein occlusion, which manifests diffuse involvement of the ret inal vascular system, and a spectrum of degrees of ischaemia;
(3) sickle retinopathy, which characteristi cally shows focal ischaemia of the periph eral retina due to small arteriolar obstruction, with presumed mostly normal retina elsewhere, In the ensuing discussion the differences in angiographic and electrophysiological find ings for each entity, will be related to the dis lribution of neovascularisation, and the prognostic values of these tests ( Previous correlative cross-sectional studies have shown a definite positive association between the presence and extent of retinal new vessels, and the location and extent of retinal vascular nonperfusion. It is important to note, although it is not widely appreciated, that new vessels on the disc (NVD) in diabetes are found primarily in eyes with extensive ischaemia. 2 7 It has also been shown that the presence of NVD carries a poor prognosis for retaining vision, if the eye is not treated with laser photocoagulation. In fact, the presence of NVD was found to be one of the major risk factors for severe visual loss in the Diabetic Retinopathy Study. 2 8 The poor prognosis undoubtedly relates to the association of NVD with severe ischaemia; that is, the pres ence of NVD, in most but not all cases, is an indicator of an eye with poor retinal perfusion.
What ocular factors can be used to identify those eyes with NPDR that are at highest risk to develop new vessels, and particularly PDR with 'DRS high-risk characteristics?' The Early Treatment Diabetic Retinopathy Study (ETDRS) has shown that the severity of ret inal haemorrhages and microaneurysms, intraretinal microvascular abnormalities (IRMA) and venous beading (graded in stan dard stereoscopic fundus photographs) are leakage is a useful predictor of PDR, because it is often easier to diagnose than nonpcr fusion, and because it tends to be more generalised than nonperfusion. Thus diffuse leakage in the posterior retina is often partof a generalised retinal vascular permeabilit¥ defect, whereas ischaemia is often more focal more peripheral and more difficult to demon strate in the face of a small pupil, media opac ities, or light fundus pigmentation. 21,22
The ERG provides an additional clinical measure of the risk of neovascularisation in eyes with diabetic retinopathy. The most use ful component in this respect is the oscillatory potentials (OPs), high frequency wavelets on the ascending limb of the b-wave. The OPs are thought to arise in the inner retinal layers, possibly reflecting feedback signals flowing in a radial direction (inner retina toward outer retina)3 0 ,31 and perhaps arising in the bipolar cells. 32 This component of the ERG is especi ally sensitive to retinal ischaemia, and the OP amplitude may be abnormal in diabetes in the presence of normal a-and b-wave amplitudes.
Reduction in the OP amplitudes correlates with the presence and severity of diabetic ret inopathy. 2o,33 There is a close correlation with both capillary non-perfusion and leakage in fluorescein angiograms. 33,34 Two longitudinal studies have shown that reduced OP ampli tudes predict the development of neovascu larisation;19,2o,21,22 one of these studies21 , 22 showed that reduced OP amplitudes predict the development of DRS-high risk character istics, a useful finding since eyes with these characteristics should generally receive prompt panretinal photocoagulation treat ment.
Other ERG measures that correlate with retinopathy severity in diabetes are the tem poral aspects of the response (implicit times of the 30 Hz flicker and OPS),35 and the 'sensitiv ity' of the retina as measured in the scotopic b-w ave intensity-response function. 36 Neither of these ERG measures has yet been shown to predict progression to new vessels.
It is particularly instructive, from the pathophysiological viewpoint, to examine the b-wave intensity response function in diabetic retinopathy, and to compare the function in CRVO and sickle cell retinopathy. When the scotopic b-wave amplitude is measured at a series of increasing stimulus intensities, the resulting data points can be fitted to an expo nential equation, known as the Naka-Rush ton function. 37 The following parameters can be derived from the curve: Rmax (the theoretical maximum b-wave response); log k (the half-saturation constant, i.e, the stimulus intensity at which one-half the Rmax is reached); n (the slope of the linear portion of the function). It has been proposed by Massof et al. 38 that a reduction in Rmax may indicate a loss of responding retinal units, as with infarc tion of the retina, while an elevation of log k may represent a reduction in the retinal sensi tivity, as can occur with retinal hypoxia or a metabolic abnormality in the retina. If it is true that hypoxic retina, but not infarcted ret ina, is the source of the presumed neovas culogenesis factor in the vascular retinopathies, then one would expect log k to be a better predictor of new vessel formation than Rmax.
Our preliminary results on the Naka-Rush ton parameters in diabetic retinopathy indi cate that both Rmax reduction and log 'k elevation occur in the same eye, although the highest correlation with retinopathy severity appears to be for log k. * It is also noteworthy, however, that the extent of log k elevation is much less in the typical eye with PD R than it is in eyes with ischaemic CRVO. 39 This probably relates to diabetic retinopathy being a more slowly evolving disease, and one with focal ischaemic involvement: at any given point in time in diabetic retinopathy, there are areas of retinal atrophy due to prior ischaemic infarc tion, areas of hypoxia due to more recent focal ischaemia, and areas with relatively normal vascular perfusion. This heterogen eous picture should result in some response compression (reduction in Rmax) from the infarcted areas, reduced retinal sensitivity (elevated log k) from the hypoxic areas, and some relatively normally responding units. The net effect would be a relatively modest change in Rmax or log k at any given point in time, unless there is extensive infarction, or florid widespread active ischaemia. One would not expect the Naka-Rushton para meters to be particularly good predictors of neovascularisation in diabetic retinopathy except, perhaps, in the florid cases. As we shall see below, the retinal sensitivity as measured by log k may be the best ERG pre dictor for the development of iris new vessels in CRVO, because of the more acute and generalised nature of the vascular involve ment in that condition. In contrast, the retinal sensitivity is probably a poor predictor of ret inal neovcascularisation in sickle cell retino pathy, because of the focal nature of vascular obstruction in that condition. 40 Additional factors that may well affect the ERG response in diabetes besides capillary nonperfusion are (1) metabolic derangement from the diabetes itself, (2) associated elec trolyte abnormalities due to insulin/blood sugar effects and renal disease, and (3) retinal vascular permeability changes affecting the extracellular ionic environment of the neu rons. It is very difficult to know how much each of these contribute to ERG abnormal ities in a given case.
The following caset is an example of a patient with moderately severe NPDR with fluorescein angiographic and ERG changes indicating high risk for developing PDR. For reference purposes to the ERG results, a normal ERG in a 31 year old nondiabetic volunteer is presented first. (Fig. 1.) (Table  II. )
Case 1
• Sixty-four year old woman with insulin dependent diabetes for 25 years. December 1986.
• Fundi-moderately severe NPDR OU (Fig. 2a, 2b ) -moderate retinal haemorrhages -hard exudate formation --(;otton wool spots -dilated, beaded veins • Fluorescein angiogram OU (Fig. 2c) -severe capillary nonperfusion -severe leakage ERG Results (Table III. ) (Fig 2d) November 1988 Over next two and one-half years, both eyes developed new vessels elsewhere (NVE).
• Fundi OU -retinal haemorrhages, cotton wool spots, venous beading worse.
-new vessels (NVE) in superior nasal quadrants OU • Fluorescein angiogram OU (Fig. 2e) .
-increased capillary nonperfusion -new vessel leakage superior nasal quadrants OU April 1989
• Six months later the left eye developed NVD. Panretinal photocoagulation was performed in the left eye with regression of new vessels.
Summary:
Severely reduced ERG oscillatory potentials and delayed 30 Hz flicker timing along with severe fluorescein angiographic nonperfusion and leakage indicated a high risk for develop ing PpR. New vessels elsewhere developed in both eyes within two years, and NVD in the left eye in 2! years.
The next case shows asymmetric diabetic retinopathy (PDR one eye, NPDR fellow eye) with ERG changes in the fellow eye indi cating a high risk for developing PDR. Flu orescein angiography could not be obtained because of nuclear sclerotic lens changes.
Case 2
• Sixty-six year old man with insulin-depend ent diabetes for 12 years. January 1986 • Fundi (Fig. 3a, 3b, 3c OSCILLATORY PoTENTIALS OD �-56UV Fig 3d(3) .
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Fig3e . Fig. 3c ). I<'i g 4c developed NVD, as well as rubeosis iridis involving the angle (8 months following extra capsular cataract surgery and posterior cham ber lens implant). Panretinal photo coagulation was performed with resultant partial regression of the NVD and full regres sion of the rubeosis. The intraocular pressure remained normal throughout the period of observation.
PHOTOPIC FLICKER
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• Fundus OS (Fig. 3e) -NVD -Ischaemic retinal swelling nasal to disc.
Summary:
Severely reduced ERG oscillatory potentials, delayed flicker timing, and reduced retinal sensitivity (elevated log k) in both eyes, with PDR in the right eye only, indicated a high risk for PDR in the fellow left eye. A strong argument could be made for earlier panretinal photocoagulation of the fellow eye, which did, in fact, develop PDR and rubeosis iridis within an 18 month period. Response to sub sequent panretinal photocoagulation was sat isfactory. (The cataract surgery probably contributed to the development of rubeosis iridis in an eye with ischaemic retinal changes).
In the following case, new vessels and capil lary nonperfusion were located preferentially in the midperipheral fundus; ERG abnormal ities alerted the clinician to the need for care ful midperipheral fundus examination and angiograph y .
Case 3
• Forty-nine year old man with insulin dependent diabetes for 22 years. April 1987 • Fundi OU (Fig. 4a, 4b) -midperipheral retinal haemorrhages -midperipheral new vessels -mild retinal abnormalities in posterior fundus • Fluorescein angiogram OU (Fig. 4c) - 10 or more disc areas of nonperfusion should be classified as ischaemic, and less than 10 disc areas, non-ischaemic. 13 , 16 However, it is important to specify how much of the fundus is being photographed in such a classification. It now is apparent that the mid-peripheral fundus as well as the posterior fundus must be evaluated for non-perfusion, and it is possible that some eyes developing NVI that were classified angiographically as non-ischaemic would have shown far more peripheral non perfusion if more completely photographed.
There are several difficulties in relying strictly on fluorescein angiography to classify the degree of ischaemia in CRVO. It has been demonstrated that there can be considerable variation among retina specialists in the inter pretation of nonperfusion in a given angio gram from an eye with CRVO. 4 2 It also can be difficult to detect nonperfusion when an eye with CRVO has extensive retinal haemor rhage. In addition, high quality angiograms are difficult to obtain in eyes with media opac-ities or small pupils, not an unusual combi nation in older patients with CRVO. In a series of 140 eyes followed over five years, Hayreh et al. 18,43 found the test which best dis tinguished ischaemic from non-ischaemic CRVO in the early acute phase to be the rela tive afferent pupillary defect, followed closely by ERG abnormalities (b-and a-wave ampli tude and b/a wa.ye amplitude ratios) and visual field constriction and visual acuity reduction; angiographically determined non perfusion and ophthalmoscopy were con siderably less effective than the various func tional measures.
Johnson et al. 39 have found the ERG to be an excellent predictor of NVI in eyes with CRVO. Of the parameters measured, log k was the most effective, scotopic b-wave and a-wave implicit times somewhat less effective, and Rmax and b/a wave amplitude ratios least effective in distinguishing those eyes with NVI at the time of ERG testing, or those developing NVI during follow-up. Interest ingly, oscillatory potential amplitude reduc tion has been found to be only a moderately good predictor of NVI in CRVO,44 probably because these potentials are too easily affected by widespread retinal circulatory dis turbance. That is, because the OPs are so sen sitive to ischaemia, they probably do not allow adequate discrimination between mil der and more severe ischaemia in CRVO (Table I) . Additional work on the value of various ERG parameters as predictors of NVI development has come from several other laboratories. 45, 46, 47 Johnson's initial work also indicated that the ERG was more effective than angiography in predicting NVl. 39 When a group of 'retina experts' were given angio grams from paired eyes of different patients with CRVO (one eye that did and one that did not develop NVI), and were asked to select the one that developed NVI, their results were less accurate than was simply choosing the eye with the more abnormal ERG. A sub sequent study from the same group suggested that applying a standardised grading system to the angiograms improved the predictive power of angiography. 48 The Central Vein Occlusion Study (CVOS) is a prospective collaborative clinical trial that is testing angiography and ERG (both of which are performed and graded in a standard fashion) for their ability to predict the development of NVl. 41 The relatively large number of patients being followed in this study should help clarify the relative value of these two tests (considered separately and combined) in following patients with CRVO.
C. Sickle Cell Retinopathy
Examining sickle cell ret.inopathy provides a very instructive comparative example to help understand the basis of ERG abnormalities in diabetic retinopathy and CRVO: the ischae mia in sickle cell retinopathy is strictly focal (due to capillary/arteriolar obstruction) and there is no systemic metabolic abnormality to confound the issues. The work of Peachey and colleagues40,49 in sickle cell retinopathy clearly shows that: (1) focal ischaemia alone causes reduction in ERG amplitudes (a-wave, b-wave, and oscillatory potentials) (2) impli cit times are generally normal (presumably because the retina outside ischaemic areas is functioning normally) (3) 'retinal sensitivity' as measured by log k (and reflected in implicit times as well) is generally normal or only mildly abnormal. 40 In their first reported study, Peachey et al. 49 showed that the oscilla tory potential amplitudes were reduced in eyes with peripheral retinal new vessels com pared to eyes without new vessels. Their second report40 described the relationship between several ERG parameters and periph eral retinal non perfusion measured angio graphically: both a-and b-wave amplitudes were reduced in eyes with peripheral nonper fusion, and decreases in amplitude were correlated with the extent of nonperfusion. Similarly, for eyes with peripheral nonper fusion the scotopic b-wave intensity-response series showed a reduced Rmax, but generally normal log k. Eyes with peripheral new vessels also had reduced Rmax, but only mar ginally elevated log k. Implicit times were again for the most part normal. As expected, there was a close correlation between the presence and extent of peripheral nonperfu sion and the presence of peripheral new vessels (Table I) . No longitudinal studies have yet been reported in sickle cell retinopathy to determine the power of the ERG to predict new vessel formation.
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